Therapeutic Outcomes of Neoadjuvant Chemotherapy Combined with Pertuzumab for HER2—Positive Breast Cancer

Authors

Institutions

Publication Details

Journal
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
Published
2025-01-01
DOI
https://doi.org/10.3919/jjsa.86.356
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Therapeutic Outcomes of Neoadjuvant Chemotherapy Combined with Pertuzumab for HER2—Positive Breast Cancer

Yoshiko Shimizu, Hisami Yoneda, Akiko Ogiya
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
HER2/EGFR in Cancer Research
article

Therapeutic Outcomes of Neoadjuvant Chemotherapy Combined with Pertuzumab for HER2—Positive Breast Cancer

Yoshiko Shimizu, Hisami Yoneda, Akiko Ogiya
article en

Abstract

No abstract available for this paper.
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)Vol. 86(3)
Japanese Red Cross Medical Center (JP)
Openalex Percentile: Top 64%
HER2/EGFR in Cancer Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Therapeutic Outcomes of Neoadjuvant Chemotherapy Combined with Pertuzumab for HER2—Positive Breast Cancer — Yoshiko Shimizu, Hisami Yoneda, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) (2025) | TGRS Research Map | TGRS